Teva Pharmaceutical Industries ADR
(TEVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 1,749,850 | 1,282,400 | 1,115,920 | 1,116,890 | 953,780 |
| Cost of Goods | 1,057,970 | 767,620 | 694,760 | 680,880 | 594,050 |
| Gross Profit | 691,870 | 514,770 | 421,160 | 436,010 | 359,720 |
| Operating Expenses | 412,610 | 316,350 | 276,850 | 262,980 | 230,470 |
| Operating Income | 280,240 | 199,050 | 145,070 | 173,910 | 129,310 |
| Interest Expense | 0 | 30,160 | 28,530 | 45,560 | 44,310 |
| Other Income | -71,880 | -6,930 | -17,700 | 11,260 | 8,320 |
| Pre-tax Income | 208,360 | 161,960 | 98,840 | 139,610 | 93,320 |
| Income Tax | 59,560 | 44,330 | 30,880 | 38,720 | 20,890 |
| Net Income Continuous | 184,117 | 135,553 | 97,107 | 122,493 | 88,322 |
| Net Income | $148,410 | $117,830 | $68,830 | $101,490 | $73,420 |
| EPS Basic Total Ops | 0.29 | 0.24 | 0.14 | 0.21 | 0.15 |
| EPS Basic Continuous Ops | 0.36 | 0.27 | 0.19 | 0.25 | 0.18 |
| EPS Diluted Total Ops | 0.29 | 0.24 | 0.14 | 0.21 | 0.15 |
| EPS Diluted Continuous Ops | 0.35 | 0.27 | 0.19 | 0.25 | 0.18 |
| EBITDA(a) | $280,240 | $199,050 | $145,070 | $173,910 | $129,310 |